Tumor Response Time of Palbociclib in Combination With AI in Real-world Chinese Patients

NCT04858997 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Palbociclib
DRUG: AI

Sponsor

Zhejiang Cancer Hospital

Collaborators

[object Object]